165 related articles for article (PubMed ID: 28370729)
1. Are very high cumulative doses of narrowband UVB safe in vitiligo?
Momen S; Sarkany R
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):220-221. PubMed ID: 28370729
[No Abstract] [Full Text] [Related]
2. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
4. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients.
Percivalle S; Piccinno R; Caccialanza M; Forti S
Pediatr Dermatol; 2012; 29(2):160-5. PubMed ID: 22329609
[TBL] [Abstract][Full Text] [Related]
5. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
6. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.
Mohammad TF; Al-Jamal M; Hamzavi IH; Harris JE; Leone G; Cabrera R; Lim HW; Pandya AG; Esmat SM
J Am Acad Dermatol; 2017 May; 76(5):879-888. PubMed ID: 28216034
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
Adauwiyah J; Suraiya HH
Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
[TBL] [Abstract][Full Text] [Related]
8. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
9. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
10. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation.
Goren A; Salafia A; McCoy J; Keene S; Lotti T
Dermatol Ther; 2014; 27(4):195-7. PubMed ID: 24548413
[TBL] [Abstract][Full Text] [Related]
11. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
12. Twenty-year follow-up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy.
Lommerts JE; Njoo MD; de Rie MA; Wolkerstorfer A; Bekkenk MW
Br J Dermatol; 2017 Sep; 177(3):e60-e61. PubMed ID: 28117877
[No Abstract] [Full Text] [Related]
13. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
14. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis.
Wu YH; Chou CL; Chang HC
Clin Exp Dermatol; 2022 Apr; 47(4):692-699. PubMed ID: 34762747
[TBL] [Abstract][Full Text] [Related]
15. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
Chiu SH; Liu IL; Chen YW; Lan CE
J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
[No Abstract] [Full Text] [Related]
16. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo?
Majid I
Indian J Dermatol Venereol Leprol; 2010; 76(3):254-8. PubMed ID: 20445295
[TBL] [Abstract][Full Text] [Related]
17. Impact of Ultraviolet Light on Vitiligo.
Singh RK
Adv Exp Med Biol; 2017; 996():55-60. PubMed ID: 29124690
[TBL] [Abstract][Full Text] [Related]
18. The Role of CXCL10 and IL-18 as Markers of Repigmentation Response in Nonsegmental Vitiligo Treated with Narrowband UVB Phototherapy: A Prospective Cohort Study.
Hojman L; Cabrera R; Karsulovic C; Tempio F; Perez C; López M
J Invest Dermatol; 2021 Jul; 141(7):1833-1836.e1. PubMed ID: 33453262
[No Abstract] [Full Text] [Related]
19. Narrowband UVB therapy for vitiligo: does the repigmentation last?
Sitek JC; Loeb M; Ronnevig JR
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
